+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Bone Marrow Transplant Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Bone Marrow Transplant Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ear Infection Treatment Market 2024-2028 - Product Thumbnail Image

Ear Infection Treatment Market 2024-2028

  • Report
  • June 2024
  • 142 Pages
  • Global
From
Herpes Treatment Market 2024-2028 - Product Thumbnail Image

Herpes Treatment Market 2024-2028

  • Report
  • May 2024
  • 171 Pages
  • Global
From
From
From
From
US Urinary Tract Infection Therapeutics outlook to 2028 - Product Thumbnail Image

US Urinary Tract Infection Therapeutics outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more